Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety

BACKGROUND AND OBJECTIVES The 9-valent human papillomavirus (9vHPV) vaccine Phase III immunogenicity study in 9- to 15-year-old boys and girls was extended to assess immunogenicity and effectiveness through 10 years after the last vaccine dose (NCT00943722). METHODS Boys (n = 301) and girls (n = 971...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pediatrics (Evanston) 2023-10, Vol.152 (4)
Hauptverfasser:	Restrepo, Jaime, Herrera, Teobaldo, Samakoses, Rudiwilai, Reina, Julio C., Pitisuttithum, Punnee, Ulied, Angels, Bekker, Linda-Gail, Moreira, Edson D., Olsson, Sven-Eric, Block, Stan L., Hammes, Luciano S., Laginha, Fabio, Ferenczy, Alex, Kurman, Robert, Ronnett, Brigitte M., Stoler, Mark, Bautista, Oliver, Gallagher, Nancy E., Salituro, Gino, Ye, Min, Luxembourg, Alain
Format:	Artikel
Sprache:	eng
Schlagworte:	Children & youth Girls Human papillomavirus Immunoassay Immunogenicity Immunoglobulin G Pediatrics Vaccine efficacy Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!